Eligibility of patients with type 2 diabetes for sodium–glucose cotransporter 2 inhibitor cardiovascular outcomes trials: a global perspective from the DISCOVER study

Stéphane Pintat; Peter Fenici; Niklas Hammar; Linong Ji; Kamlesh Khunti; Jesús Medina; Fengming Tang; Eric Wittbrodt; Filip Surmont

doi:10.1136/bmjdrc-2018-000627

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

Article metrics

PDF

Epidemiology/Health Services Research

Eligibility of patients with type 2 diabetes for sodium–glucose cotransporter 2 inhibitor cardiovascular outcomes trials: a global perspective from the DISCOVER study

Online download statistics by month:

Online download statistics by month: March 2019 to April 2020

	Abstract	Full	Pdf
Mar 2019	232	228	74
Apr 2019	200	186	82
May 2019	229	223	132
Jun 2019	205	198	80
Jul 2019	188	189	71
Aug 2019	171	169	66
Sep 2019	153	153	56
Oct 2019	135	135	66
Nov 2019	82	80	72
Dec 2019	133	131	52
Jan 2020	123	112	50
Feb 2020	99	99	23
Mar 2020	99	99	39
Apr 2020	64	64	20
Total	2113	2066	883

Log in using your username and password

Main menu

Log in using your username and password

You are here

Online download statistics by month:

Online download statistics by month: March 2019 to April 2020

Read the full text or download the PDF:

Log in using your username and password